Clinical Trials Logo

Hallucinations clinical trials

View clinical trials related to Hallucinations.

Filter by:

NCT ID: NCT00308997 Completed - Schizophrenia Clinical Trials

Transcranial Magnetic Stimulation for "Voices"

Start date: February 2006
Phase: Phase 2
Study type: Interventional

This study will determine the efficacy of MRI-guided transcranial magnetic stimulation (TMS)in reducing "voices" and other symptoms experienced by people with schizophrenia and schizoaffective disorder. In addition, the study will determine duration of improvement obtained during the course of trial participation via on-going monthly contact with study participants for up to 1 year after the trial.

NCT ID: NCT00288340 Completed - Schizophrenia Clinical Trials

Quantifying Abnormalities in Cortical Activation Associated With Auditory Hallucinations Using Functional Magnetic Resonance Imaging

Start date: January 2006
Phase: N/A
Study type: Interventional

The goal of the project is to characterize abnormalities in brain structure and function related to schizophrenia. The investigators will use advanced magnetic resonance imaging (MRI) techniques to measure the degree and distribution of neuronal activity during specific cognitive tasks, alterations in neuronal connectivity, and how these are related to disease symptoms and treatment.

NCT ID: NCT00287742 Terminated - Dementia Clinical Trials

A Study of the Effectiveness and Safety of Risperidone Versus Placebo in the Treatment of Patients With Hallucinations and Delusions Associated With Alzheimer's Disease

Start date: March 2002
Phase: Phase 3
Study type: Interventional

The purpose of this study is to assess the effectiveness and safety of risperidone (an antipsychotic medication) versus placebo for the treatment of patients with hallucinations and delusions associated with Alzheimer's disease.

NCT ID: NCT00186771 Recruiting - Schizophrenia Clinical Trials

Magnetic Stimulation as a Treatment for Auditory Hallucinations in Schizophrenia

Start date: November 2004
Phase: Phase 4
Study type: Interventional

Schizophrenia is a chronic, severe, and disabling brain disease. Auditory hallucinations are the most frequent symptoms with an incident of 50% to 70% in patients. Transcranial Magnetic Stimulation (TMS) can significantly reduce symptoms of schizophrenia. TMS is capable of inducing changes in the electrical activities of the brain in humans. The purpose of this trial is to study the use of TMS to decrease auditory hallucinations in schizophrenia.

NCT ID: NCT00087542 Completed - Parkinson's Disease Clinical Trials

Treatment of Hallucinosis/Psychosis in Parkinson's Disease by an Investigational Drug

Start date: March 2004
Phase: Phase 2
Study type: Interventional

The primary objective is to demonstrate that the investigational new drug, ACP-103, is well tolerated by, and will not worsen parkinsonism in, patients with Parkinson's disease and psychosis. The secondary objectives are to determine whether ACP-103 will ameliorate psychosis in patients with Parkinson's disease and whether ACP-103 is safe in Parkinson's disease patients taking multiple anti-parkinsonian medications.

NCT ID: NCT00042159 Completed - Schizophrenia Clinical Trials

Transcranial Magnetic Stimulation (TMS) Treatment for Patients With Persistent Auditory Hallucinations

Start date: July 2002
Phase: N/A
Study type: Interventional

This study will evaluate the long-term effects of repetitive transcranial magnetic stimulation (rTMS) in patients with auditory hallucinations.